Prevalence and incidence of systemic lupus erythematosus in France: A 2010 nation-wide population-based study

Autoimmunity Reviews

Volumn 13, Issue 11, 2014, Pages 1082-1089

  Arnaud, Laurent ^a,b   Fagot, Jean Paul ^c   Mathian, Alexis ^a,b   Paita, Michel ^c   Fagot Campagna, Anne ^c   Amoura, Zahir ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

Author keywords

Administrative database; Epidemiology; Incidence; Prevalence; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CARIBBEAN; CHILD; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; REVIEW; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; FACTUAL DATABASE; LUPUS ERYTHEMATOSUS, SYSTEMIC;

AGE DISTRIBUTION; DATABASES, FACTUAL; FRANCE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE;

EID: 84908574547     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.08.034     Document Type: Review

References (39)

1. Bernatsky S., Boivin J.F., Joseph L., Manzi S., Ginzler E., Gladman D.D., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006, 54:2550-2557.
2. Devilliers H., Amoura Z., Besancenot J.F., Bonnotte B., Pasquali J.L., Wahl D., et al. LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2012, 51:1906-1915.
3. Bernatsky S., Joseph L., Pineau C.A., Tamblyn R., Feldman D.E., Clarke A.E. A population-based assessment of systemic lupus erythematosus incidence and prevalence-results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 2007, 46:1814-1818.
4. Jakes R.W., Bae S.C., Louthrenoo W., Mok C.C., Navarra S.V., Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 2011, 64:159-168.
5. Hiraki L.T., Feldman C.H., Liu J., Alarcon G.S., Fischer M.A., Winkelmayer W.C., et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum 2012, 64:2669-2676.
6. Lim S.S., Bayakly A.R., Helmick C.G., Gordon C., Easley K., Drenkard C. The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia Lupus Registry. Arthritis Rheum Feb 2014, 66(2):357-368.
7. Somers E.C., Marder W., Cagnoli P., Lewis E.E., Deguire P., Gordon C., et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology & Surveillance (MILES) Program. Arthritis Rheumatol Feb 2014, 66(2):369-378.
8. Borchers A.T., Naguwa S.M., Shoenfeld Y., Gershwin M.E. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010, 9:A277-A287.
9. Cervera R., Doria A., Amoura Z., Khamashta M., Schneider M., Guillemin F., et al. Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev 2014, 13:621-629.
10. Hayter S.M., Cook M.C. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 2012, 11:754-765.
11. Chiu Y.M., Lai C.H. Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 2010, 19:1250-1255.
12. Laustrup H., Voss A., Green A., Junker P. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study. Lupus 2009, 19:239-246.
13. Peschken C.A., Esdaile J.M. Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 2000, 27:1884-1891.
14. Tuppin P., de Roquefeuil L., Weill A., Ricordeau P., Merliere Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique 2010, 58:286-290.
15. World Health Organisation International Statistical Classification of Diseases and Related Health Problems 10th Revision [cited 12/23/2013]; Available from:. http://apps.who.int/classifications/icd10/browse/2010/en.
16. Païta M., Weill A. Patients with long term disease on 31 December 2008 [cited]; Available from:. http://www.ameli.fr/fileadmin/user_upload/documents/27_-_ALD_2008.pdf.
17. Agence technique de l'information sur l'hospitalisation [Statistiques par GHM]. 2010 [cited 12/23/2013]; Available from:. http://stats.atih.sante.fr/mco/statghmmco.php.
18. Katz U., Zandman-Goddard G. Drug-induced lupus: an update. Autoimmun Rev 2010, 10:46-50.
19. National Institute of Statistics and Economic Studies [Populations légales 2010]. [cited 12/23/2013]; Available from:. http://www.insee.fr/fr/ppp/bases-de-donnees/recensement/populations-legales/default.asp.
20. Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard [cited 12/23/2013]; Available from:. http://www.who.int/healthinfo/paper31.pdf.
21. Doll R., Smith P. Comparison between registries: age-standardized rates. Cancer incidence in five continents 1982, 671-675. IARC Scientific Publications, Lyon (France). J. Waterhouse, C. Muir, K. Shanmugaratnam (Eds.).
22. Scotland. GROf. Age-standardised death rates using the European Standard Population [cited 12/23/2013]; Available from:. http://www.gro-scotland.gov.uk/files2/stats/age-standardised-death-rates-esp/age-standardised-death-rates-esp-background.pdf.
23. Lerang K., Gilboe I., Garen T., Thelle D.S., Gran J.T. High incidence and prevalence of systemic lupus erythematosus in Norway. Lupus 2012, 21:1362-1369.
24. Patel M., Clarke A.M., Bruce I.N., Symmons D.P. The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient. Arthritis Rheum 2006, 54:2963-2969.
25. Govoni M., Castellino G., Bosi S., Napoli N., Trotta F. Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. Lupus 2006, 15:110-113.
26. Johnson A.E., Gordon C., Palmer R.G., Bacon P.A. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995, 38:551-558.
27. Hopkinson N.D., Doherty M., Powell R.J. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol 1993, 32:110-115.
28. Nived O., Sturfelt G., Wollheim F. Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol 1985, 24:147-154.
29. Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 1985, 14:43-46.
30. Alonso M.D., Llorca J., Martinez-Vazquez F., Miranda-Filloy J.A., Diaz de Teran T., Dierssen T., et al. Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study. Medicine (Baltimore) 2011, 90:350-358.
31. Cervera R., Khamashta M.A., Hughes G.R. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 2009, 18:869-874.
32. Dadoniene J., Adomaviciute D., Rugiene R., Luksiene A., Venalis A. The prevalence of systemic lupus erythematosus in Lithuania: the lowest rate in Northern Europe. Lupus 2006, 15:544-546.
33. Commission of the European Communities Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Rare Diseases: Europe's challenges [cited 12/23/2013]; Available from:. http://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf.
34. Feldman C.H., Hiraki L.T., Liu J., Fischer M.A., Solomon D.H., Alarcon G.S., et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum 2012, 65:753-763.
35. Calixto O.J., Anaya J.M. Socioeconomic status. The relationship with health and autoimmune diseases. Autoimmun Rev 2014, 13:641-654.
36. Moroni L., Bianchi I., Lleo A. Geoepidemiology, gender and autoimmune disease. Autoimmun Rev 2012, 11:A386-A392.
37. Oertelt-Prigione S. The influence of sex and gender on the immune response. Autoimmun Rev 2012, 11:A479-A485.
38. Institut national d'études démographiques Tableau 67 - taux de mortalité par sexe et groupe d'âges 2011 [cited 12/23/2013]; Available from:. http://www.ined.fr/fichier/t_telechargement/62616/telechargement_fichier_fr_sd2011_t67_fm.xls.
39. Pineles D., Valente A., Warren B., Peterson M.G., Lehman T.J., Moorthy L.N. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus 2011, 20:1187-1192.